Elsevier, AcademicCME and ArcheMedX Announce the All-New ThrombosisClinic.com
PHILADELPHIA, April 25, 2013
PHILADELPHIA, April 25, 2013 /PRNewswire/ --
New ThrombosisClinic.com will be the first informatics-powered, connected
learning environment for continuing education
Elsevier's Office of Continuing Medical Education (EOCME) announced today that
it is extending its existing collaboration with AcademicCME and ArcheMedX to
re-launch the ThrombosisClinic.com website. The ArcheMedX connected learning
platform will power the new site to create a collaborative learning experience
for interdisciplinary teams of clinicians.
"The all-new, ThrombosisClinic.com will be a critical resource designed to
reduce mortality and improve outcomes for patients with thromboembolic disease
by providing clinicians with a more effective and more efficient lifelong
learning solution," said Sandy Breslow, Director of the EOCME. The new site
provides a one-of-a-kind educational resource for the entire interdisciplinary
clinical team, including physicians, nurse practitioners, physician
assistants, nurses, pharmacists and other healthcare providers dedicated to
thrombosis prevention, treatment and management.
By delivering advanced education to the complete clinical team including
underserved clinical areas such as dentistry, orthopedics, and OB/GYN,
"ThrombosisClinic.com will provide clinicians from primary care to intensive
care access to evidence-based strategies that can be immediately employed in
practice," said Dr. Timothy Hayes, President of AcademicCME.
The site will centralize the clinician's natural learning actions and simplify
their lifelong learning journey. In an age when clinicians face a daily
challenge to stay current with new and emerging best practices, the all-new
ThrombosisClinic.com will introduce resources and an innovative set of
connected learning tools that clinicians need to streamline their information
gathering and support practical, lifelong learning.
Recent data suggest that the majority of clinicians are using new social
technologies for the express purpose of lifelong learning and professional
development. As a result, Brian S. McGowan, PhD, Co-Founder & Chief Learning
Officer of ArcheMedX, said, "A key innovation of the all-new
ThrombosisClinic.com site is the launch of a series of curriculum-based
"Virtual Courses" designed to more effectively educate interdisciplinary teams
as they participate in collaborative learning activities." Small, trusted
cohorts of learners will engage with faculty and assist each other in
completing educational objectives throughout the virtual courses and
collaborative learning environment.
Powered by the ArcheMedX Connected Learning Platform, the site will seamlessly
connect the virtual courses and new forms of educational content to Elsevier's
comprehensive archives of clinical publications, making it simple for
clinicians to access, review, share, and apply related educational content to
clinical practice. Access to the new Virtual Courses, collaborative learning
tools, and other educational activities on ThrombosisClinic.com will be
available for registered learners beginning in the second half of 2013.
To learn more about overall site plans and how the ArcheMedX platform and
connected learning tools are being leveraged, please contact Sandy Breslow
Director, Elsevier's Office of CME, or Timothy Hayes , MD, PhD, President of
AcademicCME. For additional information on the ArcheMedX Connected Learning
Architecture and the Natural Learning Actions Model, please contact Joel
Selzer , Co-Founder & CEO of ArcheMedX, Inc.
AcademicCME is an accredited healthcare solutions medical education company
designed to impact practice behavior and thus patient outcomes. AcademicCME
leadership draws on extensive experience with clinical research, clinical
practice and the delivery of continuing medical education. The team at
AcademicCME has a unique understanding of the dynamics between physician
behavior, patient care and practice-based educational needs. Therefore,
educational content that presents up-to-date evidence based data is
transformed into practical applications in daily clinical practice. Visit
http://www.academiccme.com for more information.
ArcheMedX is a healthcare informatics and e‐learning technology company with
the singular mission to build the structure required to transform medical
education through new connected learning and assessment models. By engineering
an informatics‐powered architecture that organizes and connects the natural
learning actions of clinicians in one system, ArcheMedX simplifies lifelong
learning and streamlines the process of educational planning, assessment and
support. Visit http://www.archemedx.com for more information.
About Elsevier Elsevier is a world-leading provider of scientific, technical
and medical information products and services. The company works in
partnership with the global science and health communities to publish more
than 2,000 journals, including The Lancet and Cell , and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier's
online solutions include ScienceDirect , Scopus , Reaxys , ClinicalKey and
Mosby's Suite , which enhance the productivity of science and health
professionals, and the SciVal suite and MEDai's Pinpoint Review , which help
research and health care institutions deliver better outcomes more
cost-effectively. A global business headquartered in Amsterdam, Elsevier
employs 7,000 people worldwide. The company is part of Reed Elsevier Group
plc, a world leading provider of professional information solutions. The group
employs more than 30,000 people, including more than 15,000 in North America.
Reed Elsevier Group plc is owned equally by two parent companies, Reed
Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London,
Amsterdam and New York Stock Exchanges using the following ticker symbols:
London: REL; Amsterdam: REN; New York: RUK and ENL.
Christopher Capot Director, Corporate Relations Elsevier +1-212-633-3164
Press spacebar to pause and continue. Press esc to stop.